Group of molecular markers for constructing sensitivity model, for predicting sensitivity of immune checkpoint inhibitor drugs in patients with advanced bladder cancer, comprises tumor protein 53, phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
用于构建敏感性模型以预测晚期膀胱癌患者免疫检查点抑制剂药物敏感性的分子标记组，包括肿瘤蛋白53、磷脂酰肌醇4,5-二磷酸3-激酶催化亚基α亚型
📄 英文摘要 English Abstract
Journal Of Experimental & Clinical Cancer Research : Cr Non-protein target drugs, especially RNA-based gene therapies for treating hereditary diseases, have been recognized worldwide. As cancer is an insurmountable challenge, no miracle drug is currently available. With the advancements in...
📄 中文摘要 Chinese Abstract
📋 英文结构化总结 English Structured Summary
摘要整理
Background:
Non-protein target drugs, especially RNA-based gene therapies for treating hereditary diseases, have been recognized worldwide. As cancer is an insurmountable challenge, no miracle drug is currently available. With the advancements in...
Methods:
N/A – The provided text does not contain methodology details.
Results:
N/A – No key findings are present in the extracted text.
Data Summary:
N/A – No quantitative results or key statistics are provided.
Conclusions:
N/A – No main conclusions are stated.
Practical Significance:
N/A – No real-world applications are mentioned.
📋 中文结构化总结 Chinese Structured Summary
背景:
非蛋白质靶点药物，尤其是用于治疗遗传性疾病的RNA基因疗法，已获得全球认可。由于癌症是一项难以逾越的挑战，目前尚无特效药物问世。随着……领域的不断进步……
方法:
不适用——所提供的文本未包含方法学细节。
结果:
不适用——所提取的文本中未呈现关键发现。
数据摘要:
不适用——未提供定量结果或关键统计数据。
结论:
不适用——未陈述主要结论。
实际意义:
不适用——未提及实际应用。